Globus Medical (GMED) Share-based Compensation (2011 - 2026)

Globus Medical (GMED) has reported Share-based Compensation for 16 consecutive years, with $13.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 88.71% year-over-year to $13.4 million; the trailing twelve-month figure through Jun 2026 stood at $50.6 million (down 57.28% YoY), and the FY2025 full-year result was $49.8 million, down 42.85% from the prior year.
• Share-based Compensation climbed to $13.4 million in Q2 2026 per GMED's latest filing, from $12.6 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $118.5 million in Q2 2025 and bottomed at $8.5 million in Q4 2022.
• Historically, Share-based Compensation has averaged $51.9 million across 5 years, with a median of $17.3 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Share-based Compensation jumped 52.76% in 2024, then sank 88.71% in 2026.
• Over 5 years, Share-based Compensation stood at $8.5 million in 2022, then jumped by 1149.56% to $106.3 million in 2023, then slumped by 88.8% to $11.9 million in 2024, then retreated by 4.11% to $11.4 million in 2025, then climbed by 17.21% to $13.4 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $13.4 million, $12.6 million, and $11.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.